![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of WNT9A mRNA | CTD | PMID:28960355 | 17beta-estradiol | multiple interactions | ISO | RGD:1312797 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of WNT9A mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of WNT9A mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1305018 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of WNT9A mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of WNT9A mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to WNT9A promoter] | CTD | PMID:19654925 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of WNT9A mRNA | CTD | PMID:25172293 | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bis4-hydroxyphenylsulfone results in increased expression of WNT9A mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of WNT9A mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | Decitabine results in increased expression of WNT9A mRNA | CTD | PMID:27915011 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:1305018 | 6480464 | Propylthiouracil results in decreased expression of WNT9A mRNA | CTD | PMID:25825206 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of WNT9A mRNA | CTD | PMID:19770486 | avobenzone | decreases expression | ISO | RGD:1312797 | 6480464 | avobenzone results in decreased expression of WNT9A mRNA | CTD | PMID:31016361 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzoapyrene affects the reaction [AHR protein binds to WNT9A promoter] | CTD | PMID:19654925 | benzo[a]pyrene | affects methylation | ISO | RGD:1312797 | 6480464 | Benzoapyrene affects the methylation of WNT9A intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | RGD:1312797 | 6480464 | Benzoapyrene results in increased methylation of WNT9A 3' UTR, Benzoapyrene results in increased methylation of WNT9A promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of WNT9A mRNA | CTD | PMID:19770486 | benzo[e]pyrene | increases methylation | ISO | RGD:1312797 | 6480464 | benzoepyrene results in increased methylation of WNT9A 3' UTR | CTD | PMID:30157460 | bisphenol A | affects expression | ISO | RGD:1305018 | 6480464 | bisphenol A affects the expression of WNT9A mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of WNT9A mRNA | CTD | PMID:30951980 | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of WNT9A mRNA | CTD | PMID:30951980 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of WNT9A mRNA | CTD | PMID:20478370 | calcitriol | increases expression | ISO | RGD:1312797 | 6480464 | Calcitriol results in increased expression of WNT9A mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | RGD:1312797 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of WNT9A mRNA | CTD | PMID:21592394 | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes, Carbon affects the expression of WNT9A mRNA | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | RGD:1305018 | 6480464 | Chlorpyrifos results in decreased expression of WNT9A mRNA | CTD | PMID:18502319 | cisplatin | increases expression | ISO | RGD:1312797 | 6480464 | Cisplatin results in increased expression of WNT9A mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:1312797 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of WNT9A mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | RGD:1312797 | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of WNT9A mRNA | CTD | PMID:30911355 | copper(0) | multiple interactions | ISO | RGD:1312797 | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of WNT9A mRNA | CTD | PMID:30911355 | Deguelin | decreases expression | ISO | RGD:1312797 | 6480464 | deguelin results in decreased expression of WNT9A mRNA | CTD | PMID:19861542 | diazinon | affects expression | ISO | RGD:1305018 | 6480464 | Diazinon affects the expression of WNT9A mRNA | CTD | PMID:19130878 | diazinon | decreases expression | ISO | RGD:1305018 | 6480464 | Diazinon results in decreased expression of WNT9A mRNA | CTD | PMID:18502319 | dieldrin | affects expression | ISO | RGD:1305018 | 6480464 | Dieldrin affects the expression of WNT9A mRNA | CTD | PMID:19130878 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of WNT9A mRNA | CTD | PMID:20880076 | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of WNT9A mRNA | CTD | PMID:30319688 | fenamidone | increases expression | EXP | | 6480464 | fenamidone results in increased expression of WNT9A mRNA | CTD | PMID:27029645 | fluoranthene | multiple interactions | EXP | | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of WNT9A mRNA | CTD | PMID:28329830 | fluoranthene | decreases expression | EXP | | 6480464 | fluoranthene results in decreased expression of WNT9A mRNA | CTD | PMID:28329830 | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of WNT9A mRNA | CTD | PMID:22609695 | methapyrilene | increases methylation | ISO | RGD:1312797 | 6480464 | Methapyrilene results in increased methylation of WNT9A 3' UTR | CTD | PMID:30157460 | mitomycin C | increases expression | EXP | | 6480464 | Mitomycin results in increased expression of WNT9A mRNA | CTD | PMID:25270620 | nickel atom | affects expression | ISO | RGD:1305018 | 6480464 | Nickel affects the expression of WNT9A mRNA | CTD | PMID:19130878 | nickel subsulfide | decreases expression | ISO | RGD:1305018 | 6480464 | nickel subsulfide results in decreased expression of WNT9A mRNA | CTD | PMID:24952340 | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of WNT9A mRNA | CTD | PMID:23608068 | Soman | decreases expression | ISO | RGD:1305018 | 6480464 | Soman results in decreased expression of WNT9A mRNA | CTD | PMID:19281266 | testosterone | increases expression | ISO | RGD:1312797 | 6480464 | Testosterone results in increased expression of WNT9A mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | RGD:1312797 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of WNT9A mRNA | CTD | PMID:21592394 | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of WNT9A mRNA | CTD | PMID:17484886 | triclosan | increases expression | ISO | RGD:1312797 | 6480464 | Triclosan results in increased expression of WNT9A mRNA | CTD | PMID:30510588 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of WNT9A mRNA | CTD | PMID:17292431 | valproic acid | increases methylation | ISO | RGD:1312797 | 6480464 | Valproic Acid results in increased methylation of WNT9A gene | CTD | PMID:29154799 | |